We describe the synthesis of novel triazole-incorporated diindolylmethanes (DIMs) using a molecular hybridization approach. The antitubercular activity of the DIMs against H37Ra (ATCC 25177) was tested in the active and dormant state. Among all the synthesized conjugates, the compounds ,, ,, ,, and displayed good antitubercular activity against both the active and dormant H37Ra strain. The compound exhibited good antitubercular activity against dormant H37Ra with an IC value of 1 μg mL and IC (MIC) value of 3 μg mL. The compounds ,, and displayed good antitubercular activity against active H37Ra with IC values of 2.19, 1.52, and 0.22 μg mL, respectively. The compounds ,, , and displayed more than 70% inhibition against the Gram-positive strain at 3 μg mL. The molecular docking study showed the binding modes of the titled compounds in the active site of the DprE1 enzyme and assisted with elucidating a structural basis for the inhibition of .
The present work
describes design of a small library of new 1,2,3-triazole-appended
bis-pyrazoles by using a molecular hybridization approach, and the
synthesized hybrids were evaluated for their antifungal activity against
different fungal strains, namely, Candida albicans, Cryptococcus neoformans, Candida glabrata, Candida tropicalis, Aspergillus niger, and Aspergillus fumigatus. All the compounds exhibited
broad-spectrum activity against the tested fungal strains with excellent
minimum inhibitory concentration values. The molecular docking study
against sterol 14α-demethylase (CYP51) could provide valuable
insights into the binding modes and affinity of these compounds. Furthermore,
these compounds were also evaluated for their antioxidant activity,
which also resulted in promising data.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.